Study On Financial Capability And Promotion Strategy Of SL PHARM

In recent years,the biopharmaceutical industry has been increasingly under the guidance of the national policy and has been increasingly prominent in the entire pharmaceutical industry.It has the characteristics of fast development,strong growth ability and large output benefit,which has brought greater economic contribution to the pharmaceutical industry as a whole.However,the industry's overall development advantages are prominent.Meanwhile,there are also some restrictive factors,such as high R&D investment,large business risk and long effective cycle.These factors will largely affect the healthy development of the biopharmaceutical industry.Financial ability can objectively reflect the business situation and operating results of enterprises,analyze the financial ability of enterprises,can provide basis for the ability to improve enterprise financial strategy formulation,plays an important role for the promotion of the competitiveness of the enterprise.This article takes the financial capabilities of SL PHARM as the research object.Based on a brief description of SL PHARM,based on the financial data of 2012-2016,analyze the financial status,operating results and cash flow of SL PHARM in the past five years.select financial ability indicators which can evaluate SL PHARM financial ability to conduct a detailed analysis of the financial capabilities of SL PHARM.Application factor analysis method to calculate the indexes,and according to the calculation to evaluate the overall financial ability of the enterprises.According to the scores of each financial capability index in the factor score coefficient matrix,the contribution rate of each capability and the indexes that affect the capacity of each capability are ranked;By comparative analysis,this paper makes comparative analysis of the indexes that influence the financial ability of SL PHARM,and expounds the changing trend of each financial capability index in the recent 5 years and reveals the gap between various financial capacity indicators and the whole industry;According to the results of the comprehensive analysis,proposes strategy to enhance its financial capability,provides reference for SL PHARM in financial decision-making and financial strategy,and can also provide reference for other enterprises in the same industry to help improve the biological the overall financial capability of the pharmaceutical industry.